20/20 GeneSystems offering is now closed and is no longer accepting investments.

INVEST IN 20/20 GENESYSTEMS TODAY!

Diagnostic Testing for COVID-19 & Cancer

20/20 GeneSystems (“20/20”) is a digital diagnostics company with the core mission of reducing cancer mortality in the U.S. and around the world through early detection.

This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

$1,320,413.60 Raised

ABOUT

HEADQUARTERS
9430 Key West Ave. Suite 100
Rockville, MD 20850

20/20 GeneSystems (“20/20”) is a digital diagnostics company with the core mission of reducing cancer mortality in the U.S. and around the world through early detection.

TERMS

20/20 GeneSystems
Overview
PRICE PER SHARE
$4.40
DEADLINE
May 16, 2020
VALUATION
$38.5M
AMOUNT RAISED
$1,320,413.60
Breakdown
MIN INVESTMENT
$501.60
MAX INVESTMENT
$2,000,002.40
MIN NUMBER OF SHARES OFFERED
2,250
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
3,340,908

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

[Company Legal Name]

Corporate Address

:

[Company Address], [CITY NAME], [STATE LOCATION] [CITY ZIP]

Offering Minimum

:

$10,000.00

Offering Maximum

:

$14,699,999.60

Minimum Investment Amount

(per investor)

:

$501.60











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

10,000

Maximum Number of Shares Offered

:

14,700,000

Price per Share

:

$1.00

Pre-Money Valuation

:

$38,499,375.00











ALL UPDATES

05.15.20

Last chance to invest! Campaign ends tonight

Thank you again to all of our investors! Our StartEngine campaign ends tonight so make sure to get in now!


20/20 Management Team



This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view 20/20’s offering circular and risks associated with this offering.

03.24.20

Over $500k raised!

Over $500,000 raised! Thank you to our early adopters and community for believing in our mission.

02.15.20

20/20's OneTest for Firefighters featured on local TV newscast in suburban Atlanta

Earlier this week a local newscast outside of Atlanta Georgia featured a story about how the Clayton County Fire Department has been using 20/20's OneTest to help their members screen for cancer.   The 3 minute story can be viewed here:

https://www.wsbtv.com/video/local-video/clayton-county-fire-debuts-medical-mobile-unit/VD5ZF5BVMZYSRH2RRZV2LBS22Q/?fbclid=IwAR1oSVUC6h8vBRQQoS9-afZgqEAPgNSLbHsJwBW-PQ9oUPA4sStm8A-ENxg

Studies by the U.S. Centers for Disease Control have proven that firefighters have a statistically significant increase in cancer incidence and death for more than a dozen cancer types (especially those of the digestive tract.)   Moreover, studies among Korean firefighters have demonstrated that annual check ups that measure several of the tumor markersin  OneTest reduce death rates.

20/20's founder is a former volunteer firefighter and a co-inventor of the company's patented BioCheck kits for screening suspicious powders.   See www.BioCheckInfo.com  Those kits have been popular with fire departments worldwide for many years.



02.07.20

20/20 presents at IBM AI Symposium this week

Earlier this week 20/20 was one of only nine start-ups invited to present at Symposium on AI for Biomedical Imaging held at IBM Research's San Jose campus.   Participants at this event included R&D leaders from IBM Research, IBM Watson Health, and leading medical schools such as Stanford and Penn.  20/20's CEO Jonathan Cohen presented the company's vision for improving early cancer detection by building machine learning algorithms that combine in-vitro (lab tests) and in-vivo (imaging) diagnostics.   For example, algorithms that integrate the levels of biomarkers like CA-125 and AFP (both part of our OneTest) with ultrasound  should substantially boost the accuracy of ovarian and liver cancer detection respectively.  At the Silicon Valley symposium we made contacts with industry and academic leaders in the field that we expect will help 20/20 execute on that vision over the coming years.   

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into 20/20 GeneSystems.

$2,500

$2,500

For those who invest $2,500, two transferable multi-cancer or lung tests

$10,000

$10,000

For those who invest $10,000, six transferable multi-cancer or lung tests.

$75,000

$75,000

For those who invest $75,000, twenty transferable multi-cancer or lung tests

$100,000

$100,000

For those who invest $100,000, a lifetime of annual cancer screenings for a spousal pair

$200,000

$200,000

For those who invest $200,000, all the above perks plus all-expenses-paid trip (airfare & lodging) for 1 to travel to Taiwan for a 2-day state-of-the-art platinum level medical checkup, including OneTest + full battery of tests for all body systems

$250,000

$250,000

For those who invest $250,000, all of the above live campaign perks for two individuals

$500,000

$500,000

For those who invest $500,000, all of the above live campaign perks for four individuals

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

SECURE

Your info is your info. We take pride in keeping it that way!

DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

RAISED
$1,320,413.60
INVESTORS
1,312
MIN INVEST
$501.60
VALUATION
$38.5M

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Blog

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.